Givaudan stock slips after Jefferies cuts target but fundamentals stay strong
Published on 09/03/2026 at 07:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan stock (ISIN CH0010645932) traded at 3,231.00 Swiss francs on the SIX Swiss Exchange on September 2, 2026, leaving the Swiss fragrance and flavors group more than 11 percent below its 52-week high after a fresh analyst downgrade and price-target cut.
Jefferies downgrade puts pressure on the shares
According to an analyst update reported by ad-hoc-news.de, Jefferies cut its rating on Givaudan from Buy to Hold on September 1, 2026 and lowered the price target from 3,700.00 Swiss francs to 3,030.00 Swiss francs.
This represents a reduction of 670.00 Swiss francs, or 18.1 percent, and positions the new target about 6.2 percent below the 3,231.00 Swiss francs level observed in SIX trading on September 2, 2026.
Additional analyst commentary compiled by The Globe and Mail confirms the Hold rating and the price target of 3,030.00 Swiss francs, putting the shares above but not far from the level Jefferies now considers fair value.
Stock trades between 52-week extremes in the SMI
Market data presented by ad-hoc-news.de shows that Givaudan stock stood at 3,231.00 Swiss francs at 09:29 on September 2, 2026 on the SIX Swiss Exchange, down about 0.7 percent in the morning compared with the previous close.
The same snapshot indicates a market capitalization of 29.84 billion Swiss francs as of September 2, 2026, underlining Givaudan's role as a heavyweight in the Swiss Market Index.
At this price, the share is 11.17 percent below its 52-week high of 3,592.00 Swiss francs and 20.58 percent above its 52-week low of 2,566.00 Swiss francs, meaning investors are currently positioned in the middle of the recent trading range rather than at an extreme.
A separate trading note from finanzen.ch reports that the stock was at 3,231.00 Swiss francs at 09:28 on September 2, 2026, marking an intraday low at the same level after an opening quote of 3,235.00 Swiss francs.
More background on Givaudan stock
For additional regulatory filings, presentations and detailed financial information on Givaudan, the SIX-listed fragrance and flavors specialist, further materials are available in the dedicated topic area.
Half-year 2026 figures underline earnings momentum
Jefferies' more cautious stance comes against the backdrop of solid fundamentals. Based on the latest earnings release for the quarter ending June 30, 2026, which is summarized in an analyst overview cited by The Globe and Mail, Givaudan reported quarterly revenue of 3.8 billion Swiss francs and net profit of 475 million Swiss francs.
In the comparable quarter a year earlier, revenue was 1.93 billion Swiss francs and net profit 296 million Swiss francs, so revenue was almost doubled while net profit increased by 179 million Swiss francs year on year.
This strong growth feeds into the full-year 2025 figures published on the company's own investor site. According to Givaudan's investor section, full-year group sales for 2025 were 7,472 million Swiss francs, up 5.1 percent on a like-for-like basis and 0.8 percent in Swiss francs compared with 2024.
The same overview shows EBITDA of 1,751 million Swiss francs, an EBITDA margin of 23.4 percent and net income of 1,071 million Swiss francs for 2025, together with a dividend of 72.00 Swiss francs per share, highlighting a combination of profitability and shareholder returns.
For investors, the recent half-year jump in revenue and profit, combined with the steady margin profile in the most recent full year, suggests that the Jefferies downgrade is driven more by valuation concerns and relative sector positioning than by a deterioration in operating performance.
Analyst view and sector positioning
The Jefferies call does not stand alone. The same analyst summary referenced by The Globe and Mail notes that Barclays has Givaudan rated Hold, while Bernstein maintains a Sell rating, underlining a divided view on valuation even as the earnings trajectory remains positive.
Separately, a recent sector note discussed in the analysis published by ad-hoc-news.de cites JPMorgan as keeping Givaudan among its preferred short-term ideas in European staples and expecting further like-for-like acceleration in the second half of the year.
The same note mentions that European staples trade at around 18 times forward earnings and about 1 percent to 2 percent below JPMorgan's consensus on 2027 estimates, suggesting that while the sector is not cheap, it is also not priced for perfection.
On the Swiss side, finanzen.ch points out that Givaudan shares were among the weaker names in the Swiss Market Index during the morning session on September 2, 2026, when the index stood around 14,322 points, but they remained comfortably above the 52-week low.
For Givaudan, this mix of cautious and constructive analyst opinions means that the stock is likely to remain sensitive to incremental data points on margins, volume growth in core categories and any major shifts in consumer staples valuations.
Fragrance and taste solutions as growth drivers
Givaudan's core business centers on fragrances and flavors that are used in consumer products ranging from perfumes and cosmetics to food and beverages. The company combines creative perfumery with ingredients expertise to offer tailored solutions to brand owners worldwide.
In recent years, Givaudan has expanded its capabilities in natural and sustainable ingredients, as well as in active beauty, positioning itself to benefit from trends toward more conscious consumer choices.
The revenue and profit growth reported for the quarter ending June 30, 2026, as summarized by analysts, reflects strong demand across these segments, with the nearly doubled revenue compared with the prior-year quarter highlighting the impact of scale, portfolio breadth and, likely, acquisitions and price initiatives.
Givaudan stock in the Swiss market
As of September 2, 2026, Givaudan stock is quoted on the SIX Swiss Exchange under the ticker GIVN at 3,231.00 Swiss francs, with a market capitalization of 29.84 billion Swiss francs according to the price snapshot used in the analyst and market commentary.
For investors comparing levels, this places the share some distance below the 3,592.00 Swiss francs 52-week high while maintaining a clear buffer above the 2,566.00 Swiss francs 52-week low, illustrating that the recent rating cut has led to a modest pullback rather than a structural breakdown.
Givaudan key data
- Company: Givaudan SA
- ISIN: CH0010645932
- Ticker: GIVN
- Trading venue: SIX Swiss Exchange
- Price (as of September 2, 2026, 09:29): 3,231.00 Swiss francs
- Market capitalization: 29.84 billion Swiss francs (as of September 2, 2026)
- Sector / Industry: Consumer staples / Fragrances and flavors
- Index membership: Swiss Market Index (SMI)
